Mirae Asset Global Investments’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $37.5K | Buy |
4,001
+537
| +16% | +$5.04K | ﹤0.01% | 1301 |
|
2025
Q1 | $28K | Buy |
3,464
+70
| +2% | +$565 | ﹤0.01% | 1343 |
|
2024
Q4 | $40.6K | Sell |
3,394
-280
| -8% | -$3.35K | ﹤0.01% | 1299 |
|
2024
Q3 | $77.2K | Buy |
3,674
+794
| +28% | +$16.7K | ﹤0.01% | 1228 |
|
2024
Q2 | $66.8K | Sell |
2,880
-214,514
| -99% | -$4.97M | ﹤0.01% | 1193 |
|
2024
Q1 | $7.73M | Buy |
217,394
+31,536
| +17% | +$1.12M | 0.02% | 743 |
|
2023
Q4 | $5.67M | Sell |
185,858
-100,885
| -35% | -$3.08M | 0.01% | 852 |
|
2023
Q3 | $9.07M | Buy |
286,743
+22,633
| +9% | +$716K | 0.02% | 650 |
|
2023
Q2 | $10.8M | Buy |
264,110
+46,381
| +21% | +$1.89M | 0.02% | 615 |
|
2023
Q1 | $8.11M | Buy |
217,729
+9,458
| +5% | +$353K | 0.02% | 717 |
|
2022
Q4 | $7.27M | Sell |
208,271
-3,152
| -1% | -$110K | 0.02% | 706 |
|
2022
Q3 | $11.8M | Buy |
211,423
+31,898
| +18% | +$1.78M | 0.03% | 520 |
|
2022
Q2 | $9.29M | Buy |
179,525
+103,651
| +137% | +$5.36M | 0.02% | 623 |
|
2022
Q1 | $5.51M | Sell |
75,874
-13,707
| -15% | -$996K | 0.01% | 840 |
|
2021
Q4 | $10.6M | Sell |
89,581
-49,434
| -36% | -$5.85M | 0.02% | 668 |
|
2021
Q3 | $18.6M | Buy |
139,015
+26,113
| +23% | +$3.5M | 0.05% | 429 |
|
2021
Q2 | $18.3M | Buy |
112,902
+1,604
| +1% | +$260K | 0.05% | 422 |
|
2021
Q1 | $8.93M | Buy |
111,298
+50,496
| +83% | +$4.05M | 0.03% | 559 |
|
2020
Q4 | $3.31M | Buy |
60,802
+23,700
| +64% | +$1.29M | 0.01% | 765 |
|
2020
Q3 | $738K | Buy |
37,102
+11,795
| +47% | +$235K | ﹤0.01% | 1072 |
|
2020
Q2 | $532K | Buy |
25,307
+9,651
| +62% | +$203K | ﹤0.01% | 1117 |
|
2020
Q1 | $191K | Buy |
15,656
+1,702
| +12% | +$20.8K | ﹤0.01% | 1323 |
|
2019
Q4 | $205K | Buy |
13,954
+3,407
| +32% | +$50.1K | ﹤0.01% | 1436 |
|
2019
Q3 | $141K | Buy |
+10,547
| New | +$141K | ﹤0.01% | 1396 |
|